Loveleen Bansi‐Matharu

MedicineImmunology and MicrobiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.744Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1878

Top 27%

0.744DataRank

Top 27%22 citations

Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Thérèse Staub, Martin Gisinger +68 more

Papers

Driven by 12 papers — median percentile 73. Top paper: “Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus”.

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1878

Top 27%

0.744DataRank

Top 27%22 citations

Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Thérèse Staub, Martin Gisinger +68 more

The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis

The Lancet Global Health(2021)10.1016/s2214-109x(21)00025-5

N/A

0DataRank · unranked

75 citations

Loveleen Bansi‐Matharu, Valentina Cambiano, Peter Ehrenkranz, Celicia Serenata, François Venter +6 more

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

The Lancet HIV(2021)10.1016/s2352-3018(21)00163-6

N/A

0DataRank · unranked

64 citations

Andrew Phillips, Cristiana Oprea, Katharina Grabmeier‐Pfistershammer, Huldrych F. Gunthard, Stéphane De Wit +36 more

Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

AIDS(2022)10.1097/qad.0000000000003373

N/A

0DataRank · unranked

36 citations

Lauren Greenberg, Bastian Neesgaard, José M. Miró, Katharina Grabmeier‐Pfistershammer, Gilles Wandeler +27 more

Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models

The Lancet Global Health(2022)10.1016/s2214-109x(22)00310-2

N/A

0DataRank · unranked

28 citations

Lise Jamieson, Hae‐Young Kim, Ingrida Platais, Masabho Milali, Edinah Mudimu +10 more

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

The Lancet HIV(2023)10.1016/s2352-3018(22)00365-4

N/A

0DataRank · unranked

64 citations

Loveleen Bansi‐Matharu, Valentina Cambiano, Dobromir Dimitrov, Anna Bershteyn, David van de Vijver +32 more

Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts

The Lancet HIV(2024)10.1016/s2352-3018(23)00328-4

N/A

0DataRank · unranked

48 citations

Mark N. Polizzotto, Fernando Maltêz, Andri Rauch, Katharina Grabmeier‐Pfistershammer, Ferdinand W.N.M. Wit +20 more

Integrase Strand Transfer Inhibitor–Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium

Clinical Infectious Diseases(2024)10.1093/cid/ciae406

N/A

0DataRank · unranked

28 citations

Loveleen Bansi‐Matharu, Matthew Law, Robert Zangerle, Andri Rauch, Philip Tarr +22 more

A risk-differentiated, community-led intervention to strengthen uptake and engagement with HIV prevention and care cascades among female sex workers in Zimbabwe (AMETHIST): a cluster randomised trial

The Lancet Global Health(2024)10.1016/s2214-109x(24)00235-3

N/A

0DataRank · unranked

25 citations

Fortunate Machingura, M. Sanni Ali, Sungai T. Chabata, Albert Takaruza, Jeffrey Dirawo +13 more

Identifying gaps in the HIV treatment cascade in Africa: a model comparison study

The Lancet Global Health(2025)10.1016/s2214-109x(25)00121-4

N/A

0DataRank · unranked

4 citations

Haroon Moolla, Daniel Citron, John Stover, Michael Pickles, Rowan Martin‐Hughes +15 more

Dynamic choice HIV prevention with long-acting injectable cabotegravir pre-exposure prophylaxis in east, central, southern, and west Africa: a cost-effectiveness modelling analysis

The Lancet HIV(2025)10.1016/s2352-3018(25)00169-9

N/A

0DataRank · unranked

1 citations

Matthew D. Hickey, Starley B. Shade, Jane Kabami, James Ayieko, Paul Revill +10 more

Decline in HIV prevalence among female sex workers in Zimbabwe between 2013 and 2023

Nature Communications(2025)10.1038/s41467-025-65901-x

N/A

0DataRank · unranked

0 citations

Harriet Jones, Tsitsi Hove, M. Sanni Ali, Loveleen Bansi‐Matharu, Fortunate Machingura +11 more

Loveleen Bansi‐Matharu

Indexed papers

Top data-sharing exemplar

Papers